Very-Low-Density Lipoprotein–Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-III

BACKGROUND: Routine apolipoprotein (apo) measurements for cardiovascular disease (CVD) are restricted to apoA-I and apoB. Here, the authors measured an unprecedented range of apolipoproteins in a prospective, population-based study and relate their plasma levels to risk of CVD. OBJECTIVES: This stud...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Am Coll Cardiol
Auteurs principaux: Pechlaner, Raimund, Tsimikas, Sotirios, Yin, Xiaoke, Willeit, Peter, Baig, Ferheen, Santer, Peter, Oberhollenzer, Friedrich, Egger, Georg, Witztum, Joseph L., Alexander, Veronica J., Willeit, Johann, Kiechl, Stefan, Mayr, Manuel
Format: Artigo
Langue:Inglês
Publié: Elsevier Biomedical 2017
Sujets:
Original Investigation
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5314136/
https://ncbi.nlm.nih.gov/pubmed/28209220
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2016.11.065
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires